Edward Gelmann

Edward Gelmann practices at University of Arizona in Tucson, Arizona.

Edward Gelmann's NPI, 1285632067, was assigned on July 14, 2005. Edward Gelmann graduated from Stanford University School of Medicine in 1976. Edward Gelmann holds New York license 243717.

Edward Gelmann's primary practice is University of Arizona, at 1501 N Campbell Ave, Tucson, AZ 85724 in Pima County. The practice phone is (520) 626-2761.

Edward Gelmann's primary practice is University of Arizona in Tucson, Arizona. Edward Gelmann is also affiliated with Banner - University Medical Center Tucson. The medical group on file is Banner Medical Group. Dmand AI also links Edward Gelmann to 2 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Edward Gelmann practices, 5 sites in all. Vendor and product names are available with a free account.

Medical oncology is Edward Gelmann's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Edward Gelmann is licensed in New York.

CMS data shows 726 Medicare services from Edward Gelmann across 3 procedure codes in 2024, all of them office visits, for 254 Medicare patients. Medicare paid $65,068 for them. Every service was in an office.

CMS counts 254 Medicare patients who saw Edward Gelmann in 2024. The largest group is 75 to 84, with 131 patients. 75% of them have cancer, and 75% have high blood pressure. 4% are also on Medicaid. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Edward Gelmann's median patient age at 76, with 8% women.

In 2024, Edward Gelmann wrote 908 Medicare Part D claims for 137 patients. 77% of them were for generic drugs. CMS names the drug for 793 of them, across 12 drugs with 11 or more claims each, at $2,620,484 in total drug cost. In 2023, CMS named 852 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Edward Gelmann for performance year 2024, reported through an alternative payment model (APM). Edward Gelmann accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 45 general payments to Edward Gelmann from 13 drug and device companies from 2016 to 2025. Acquisitions make up the largest share, 100% of the total. Zimmer Biomet Holdings, Inc. paid the most, $943,437. It also lists 3 research payments totaling $506 from 2024 to 2025, naming 1 clinical trial.

Edward Gelmann graduated from Stanford University School of Medicine in 1976.